MedPath

Efficacy of an internet-based self-management intervention for adult primary care patients with mild and moderate depression or dysthymia

Not Applicable
Conditions
F32.0
F32.1
F33.0
F33.1
F34.1
Mild depressive episode
Moderate depressive episode
Recurrent depressive disorder, current episode mild
Recurrent depressive disorder, current episode moderate
Dysthymia
Registration Number
DRKS00009323
Lead Sponsor
Stiftung Deutsche Depressionshilfe
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
347
Inclusion Criteria

Mild or moderate depression, dysthymia or recurrent depression according to MINI (ICD-10: F32.0; F32.1; F33.0; F33.1; F34.1), 18-75 years of age, outpatient status, sufficient language skills (regarding both speaking and writing) and able to meet the requirements of the study, Internet-access (privately at home or sufficient opportunity to access the internet regularly), written informed consent

Exclusion Criteria

ICD-10 diagnoses: dementia, alcohol/ drug addiction; schizophrenia; manic episode or bipolar disorder; obsessive-compulsive disorder according to MINI (F0, F1, F2, F30, F31, F42), acute suicidal tendencies, known personality disorder (F60.2, F60.31), Severe somatic disorders requiring immediate treatment, Participation in another clinical trial within the last 4 weeks, known alcohol/ drug abuse within the last 6 months, pregnancy

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Primary outcome of the study is the reduction of depressive symptoms in the treatment group compared to the control condition as measured by the IDS-SR-score after the 6 week Intervention.<br>
Secondary Outcome Measures
NameTimeMethod
Secondary outcomes are changes in depressive sympotms over the course of the intervention (PHQ-9, IDS, CGI), the acceptance and feasibility (ZUF-8) of the ifightDepressoin tool and other training effects such as changes in perceived quality of life (SF-12). We also plan to look at possible adverse effects (INEP) and moderating variables e.g. gender.<br>Measurement: <br>before the beginning of the intervention (T0: IDS, PHQ-9, CGI, SF-12)<br><br>weekly during the intervention (PHQ-9, rating of the workshops)<br><br>3 weeks after the beginning of the intervention (T1: IDS, CGI, documentation AE/SAE),<br><br>at the end of intervention (T2: IDS, PHQ-9, CGI, ZUF-8, SF-12, documentation of AE/SAE),<br><br>follow up 3, 6 and 12 Month after the end of the intervention (T3,4 and5: IDS, CGI, ZUF-8, SF-12, documentation of AE/SAE, PHQ-9)
© Copyright 2025. All Rights Reserved by MedPath